Form 8-K - Current report:
SEC Accession No. 0001564590-21-056712
Filing Date
2021-11-12
Accepted
2021-11-12 16:19:21
Documents
14
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-8k_20211112.htm   iXBRL 8-K 42763
2 EX-99.1 celu-ex991_15.htm EX-99.1 257943
  Complete submission text file 0001564590-21-056712.txt   476491

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA celu-20211112.xsd EX-101.SCH 5925
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20211112_def.xml EX-101.DEF 13885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20211112_lab.xml EX-101.LAB 23796
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20211112_pre.xml EX-101.PRE 14640
7 EXTRACTED XBRL INSTANCE DOCUMENT celu-8k_20211112_htm.xml XML 5570
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 211403826
SIC: 2834 Pharmaceutical Preparations